Sofosbuvir-ribavirin treats hepatitis C virus genotypes 2, 3

CHICAGO – Oral sofosbuvir and ribavirin given for 12 weeks produced a sustained virologic response in 93% of 250 patients with hepatitis C virus genotype 2 and in 85% of patients with genotype 3...